Is elderberry good for fatty liver? Many patients with non-alcoholic fatty liver disease (NAFLD) explore natural remedies like elderberry, drawn by its traditional use and antioxidant properties. Whilst elderberry contains compounds that reduce oxidative stress in laboratory studies, there is no clinical evidence that elderberry supplementation improves fatty liver disease in humans. NAFLD affects a substantial proportion of UK adults, and lifestyle modification—including weight loss, dietary changes, and physical activity—remains the only evidence-based treatment recommended by NICE. Before considering any supplement, patients should discuss options with their GP or hepatologist, as some herbal products may interact with medications or affect liver function.

Understanding Fatty Liver Disease and Natural Remedies

Fatty liver disease, medically termed hepatic steatosis, occurs when excess fat accumulates in liver cells. In the UK, non-alcoholic fatty liver disease (NAFLD) affects a substantial proportion of adults, making it the most common liver condition nationwide. The condition exists on a spectrum, ranging from simple steatosis (fat accumulation without inflammation) to non-alcoholic steatohepatitis (NASH), which involves inflammation and potential liver damage.

The primary risk factors include obesity, type 2 diabetes, high cholesterol, and metabolic syndrome. Many individuals remain asymptomatic in early stages. Importantly, NAFLD can be present even when liver enzymes (ALT, AST) are normal; diagnosis often occurs incidentally during imaging studies such as ultrasound scans or through systematic assessment of at-risk groups. NICE guidance (NG49) recommends using non-invasive fibrosis scores—such as the NAFLD fibrosis score or FIB-4 index—in primary care to identify patients who may have advanced fibrosis. Those with intermediate or high scores should have an Enhanced Liver Fibrosis (ELF) blood test and be considered for referral to hepatology services. Lifestyle modification remains the cornerstone of management, with no currently licensed pharmacological treatments specifically for NAFLD in the UK.

Given the limited pharmaceutical options, many patients explore natural remedies and dietary supplements as complementary approaches. Popular choices include milk thistle, turmeric, omega-3 fatty acids, and various antioxidant-rich botanicals like elderberry. Whilst the appeal of natural interventions is understandable, it is crucial to evaluate such remedies through an evidence-based lens. In the UK, the MHRA regulates herbal medicines through the Traditional Herbal Registration (THR) scheme, but many supplements—including most elderberry products—are sold as food supplements and are not assessed for efficacy or subject to the same quality controls as licensed medicines.

Patient interest in elderberry for liver health stems from its traditional use and antioxidant properties. However, there is no clinical evidence that elderberry supplementation improves fatty liver disease. Before considering any supplement, patients should discuss options with their GP or hepatologist, particularly as some herbal products may interact with medications or potentially affect liver function themselves.

What Is Elderberry and Its Potential Health Benefits

Elderberry refers to the dark purple-black berries of the Sambucus nigra plant, commonly known as black elder or European elder. This deciduous shrub grows throughout the UK and has been used in traditional medicine for centuries. The berries are rich in anthocyanins (powerful antioxidant compounds), vitamins A and C, dietary fibre, and various phenolic acids. It is important to note that raw elderberries, leaves, stems, and roots contain cyanogenic glycosides and must be cooked before consumption to reduce the risk of toxicity.

Commercially available elderberry products include syrups, capsules, lozenges, and teas. Some small, heterogeneous randomised controlled trials suggest that elderberry may modestly reduce the duration and severity of upper respiratory tract infections, particularly influenza-like illness. However, the overall evidence base is limited, and no UK clinical guidance (NICE or NHS) endorses elderberry for the prevention or treatment of colds or flu. Proposed mechanisms—such as immune modulation and inhibition of viral neuraminidase enzymes—are derived largely from laboratory and animal studies and have not been robustly demonstrated in humans. Elderberry should not be used in place of flu vaccination or prescribed antiviral medicines.

Regarding liver health specifically, elderberry's theoretical benefits relate to its high antioxidant content. Oxidative stress plays a significant role in the progression of NAFLD to NASH, and antioxidants may theoretically help mitigate cellular damage. Laboratory studies have shown that elderberry extracts possess anti-inflammatory properties and can reduce markers of oxidative stress in cell cultures. Some animal studies suggest potential hepatoprotective effects, with improvements in liver enzyme levels and reduced fat accumulation in rodent models of fatty liver disease.

However, it is essential to emphasise that preclinical findings do not automatically translate to human clinical benefit. No high-quality randomised controlled trials have specifically examined elderberry supplementation in patients with NAFLD or NASH. The existing evidence base consists primarily of in vitro studies and animal models, which cannot reliably predict efficacy or safety in human populations. Patients should be aware that marketing claims often exceed the available scientific evidence.

Evidence-Based Treatments for Fatty Liver in the UK

NICE guidance (NG49) on NAFLD emphasises that lifestyle intervention remains the primary evidence-based treatment. The cornerstone recommendations include:

• Weight loss: A reduction of 7–10% of body weight has been shown to improve liver histology, reduce hepatic steatosis, and decrease inflammation in NASH patients

• Dietary modification: Mediterranean-style diets rich in vegetables, fruits, whole grains, and healthy fats (particularly olive oil) demonstrate benefits independent of weight loss

• Physical activity: At least 150 minutes of moderate-intensity aerobic exercise weekly (in line with UK Chief Medical Officers' guidelines), combined with resistance training, improves liver fat content and metabolic parameters

• Management of comorbidities: Optimising control of diabetes, hypertension, and dyslipidaemia through appropriate medications

Assessment of fibrosis is a key component of NAFLD management. NICE recommends using the NAFLD fibrosis score or FIB-4 index in primary care to stratify patients. Those with intermediate or high scores should have an Enhanced Liver Fibrosis (ELF) blood test to identify advanced fibrosis (stage F3 or cirrhosis). Patients with suspected advanced fibrosis should be referred to hepatology services for specialist assessment, which may include transient elastography (FibroScan) or liver biopsy.

Pharmacological options remain limited in the UK. Whilst several agents show promise in clinical trials, none are specifically licensed for NAFLD treatment. Pioglitazone may be considered off-label in patients with biopsy-proven NASH, but its use requires careful specialist discussion of risks and benefits, including weight gain, bone fracture risk, fluid retention and heart failure, and a possible signal for bladder cancer. Vitamin E (800 IU daily) has demonstrated histological improvement in non-diabetic NASH patients in some studies, but it is also used off-label and carries concerns regarding long-term safety, including potential increased risks of haemorrhagic stroke and prostate cancer in some populations. GLP-1 receptor agonists are not recommended solely for NAFLD treatment outside clinical trials; they should be used only for their licensed indications (type 2 diabetes or obesity).

Patients should be counselled that no supplement, including elderberry, has sufficient evidence to recommend as treatment for fatty liver disease. The focus should remain on proven lifestyle interventions, with pharmacological therapy reserved for specific circumstances under specialist guidance and close monitoring.

Safety Considerations When Using Elderberry Supplements

Elderberry supplements are generally well-tolerated when used appropriately, but several important safety considerations warrant discussion. Raw or uncooked elderberries, leaves, stems, and roots contain cyanogenic glycosides (sambunigrin), which can release cyanide when metabolised. Commercial preparations use heat-treated berries, which substantially reduces this risk, but proper cooking is essential for homemade preparations. Symptoms of cyanide toxicity include nausea, vomiting, diarrhoea, and in severe cases, respiratory distress.

Common adverse effects of elderberry supplements include mild gastrointestinal symptoms such as nausea, abdominal cramping, and diarrhoea, particularly at higher doses. Allergic reactions, whilst uncommon, have been reported and may manifest as rash, urticaria, or respiratory symptoms. If you experience difficulty breathing, throat swelling, or other signs of a severe allergic reaction, call 999 or 112 immediately. Patients with known allergies to plants in the Adoxaceae family should avoid elderberry products.

Drug interactions represent an important consideration, though robust human data are limited. Elderberry may theoretically interact with:

• Immunosuppressants: Elderberry's immune-stimulating properties could potentially counteract medications like corticosteroids, azathioprine, or biologics

• Diabetes medications: Some limited evidence suggests elderberry may lower blood glucose, though this effect is unproven in robust human studies; patients taking antidiabetic medicines should monitor blood glucose and discuss use with their GP or pharmacist

Claims regarding interactions with diuretics and laxatives are speculative and lack supporting human evidence. Patients taking multiple medicines should check with their GP or pharmacist before starting any supplement, including elderberry.

For patients with fatty liver disease specifically, there is no evidence that elderberry supplementation improves outcomes. Some herbal supplements have been associated with drug-induced liver injury (DILI), though elderberry is not commonly implicated. Nevertheless, patients with existing liver disease should exercise caution with any supplement and discuss use with their healthcare provider.

Regulatory status in the UK means elderberry products are typically sold as food supplements rather than medicines, resulting in less stringent quality control compared with licensed medicines or products registered under the MHRA's Traditional Herbal Registration (THR) scheme. Patients should choose products from reputable manufacturers with third-party testing. The MHRA advises reporting any suspected adverse reactions through the Yellow Card Scheme at yellowcard.mhra.gov.uk.

Patients should contact their GP if they experience: persistent abdominal pain, jaundice (yellowing of skin or eyes), dark urine, pale stools, unexplained fatigue, or any concerning symptoms whilst taking supplements. These may indicate liver dysfunction requiring urgent assessment. Pregnant and breastfeeding women should avoid elderberry supplements due to insufficient safety data.

Frequently Asked Questions